RATIONAL DRUG DESIGNING: SUCCESS STORY OF INTRACELLULAR TARGETED AGENTS IN THE MANAGEMENT OF CHRONIC MYELOID LEUKEMIA

Journal Title: Asian J of Pharm Sci & Tech - Year 2014, Vol 4, Issue 3

Abstract

[u][/u] ABSTRACT Chronic myeloid leukemia (CML) is a common hematological malignancy encountered in clinical practice. This malignant disorder, is caused due to defective translocation of genetic segment between chromosome 9 and 22 (Philadelphia chromosome), that constitutively activates different proteins and enzymes and favoring cell division. The fused oncogene bcr-abl encoded Bcr-Abl is a trans membrane receptor-linked tyrosine kinase which is expressed in the leukemic clonal cells, activates many pro-growth and cell survival mechanisms. Novel tyrosine kinase Inhibitors like Imatinib mesylate is the first molecule which has proved its efficacy in many malignant disorders including CML by inhibiting cellular tyrosine kinase enzyme. After arrival of imatinib, other 2nd and 3rd generation tyrosine kinase inhibitors have also been introduced, which find their application in imatinib resistant or intolerant patients. Other intracellular targets like aurora kinase, histone deacetylase, heat shock protein 90, proteosome, that gets activated and acts downstream tyrosine kinase also has been identified and have been targeted with different novel drug molecules for their possible role in this unique disorder. This success story can be exploited for targeting other malignant disorders where these proteins get activated. Key words: Cellular tyrosine kinase, Imatinib mesylate, Aurora kinase, Histone deacetylase, Heat shock protein 90, Proteasome.

Authors and Affiliations

Trupti Rekha Swain, Niranjan Rout, Rabindra kumarJena

Keywords

Related Articles

 Formulation and evaluation of sustained release oral matrix tablet by using rifampicin as a model drug

 ABSTRACT The present study was aim to formulate and evaluate the sustained release oral matrix tablet by using rifampicin as a model drug and see the effects of different polymers to prolong the release of drug f...

 CHEMICAL CONSTITUENTS AND PHARMACOLOGICAL EFFECTS OF ASTRAGALUS HAMOSUS AND ASTRAGALUS TRIBULOIDES GROWN IN IRAQ

 ABSTRACT Two members of Astragalus genus grown in Iraq, Astragalus hamosus and Astragalus tribuloides. They possessed a wide range of pharmacological effects. This review highlight the chemical constituents and p...

 Pharmacological studies of anti diarrhoeal activity of Casuarina equisetifolia (L.) in experimental animals

 ABSTRACT The purpose of the present study was to evaluate scientifically the anti-diarrhoeal effects of ethanolic (90%) extract of Casuarina equisetifolia Linn (EECE) was studied against castor oil-induced-diarrh...

 ACCURACY OF MALARIA DIAGNOSIS AND PRESCRIBING PATTERNS FOR FEBRILE UNDERFIVES IN AN AREA WITH DECLINING MALARIA BURDEN, NORTHEASTERN TANZANIA

 ABSTRACT This study examined the accuracy of clinical diagnosis and rapid malaria diagnostic test (mRDT) for the prediction of malaria; and the patterns of prescription for febrile underfives in a setting with re...

 URVEY OF CHARYBDIS LUCIFERA (FABRICIUS, 1798) LANDINGS IN PARANGIPETTAI COAST, SOUTH EAST COST OF INDIA.

 ABSTRACT The economically and pharmaceutically important portunid crabs found along east coast of India. Most of the edible crabs in India come under the family Portunidae i.e., out of 16 species are S.serrata, S...

Download PDF file
  • EP ID EP118106
  • DOI -
  • Views 161
  • Downloads 0

How To Cite

Trupti Rekha Swain, Niranjan Rout, Rabindra kumarJena (2014).  RATIONAL DRUG DESIGNING: SUCCESS STORY OF INTRACELLULAR TARGETED AGENTS IN THE MANAGEMENT OF CHRONIC MYELOID LEUKEMIA. Asian J of Pharm Sci & Tech, 4(3), 138-146. https://europub.co.uk/articles/-A-118106